Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 0 | -240.54%-52 | -120.93%-9 | 0.00%-1 | -400.00%-21 | -75.00%-21 | 268.18%37 | 168.75%43 | 50.00%-1 | 138.89%7 |
| Net income from continuing operations | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.90%-160.78K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -1.63%-142.42K | 0.41%-139.71K |
| Asset impairment expenditure | ---- | --2 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | --608.02K | ---- | ---- | ---- |
| Other non cashItems | 20.01%162.17K | 10.94%596.37K | 20.01%162.17K | 18.70%158.65K | 5.06%140.42K | 0.00%135.13K | 0.27%537.58K | 0.00%135.13K | 1.11%133.66K | 0.00%133.66K |
| Change In working capital | -79.70%2.1K | -15.50%29.74K | 6.85%11.91K | -75.61%2.14K | -11.92%5.34K | 12.20%10.35K | 16.14%35.19K | 12.23%11.15K | 10.31%8.76K | -8.34%6.06K |
| -Change in receivables | 78.09%-177 | 24.46%-1.23K | 69.57%-63 | 92.31%-28 | 68.10%-333 | -4,950.00%-808 | -32.82%-1.63K | -590.00%-207 | 3.45%-364 | -71.15%-1.04K |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Change in payables and accrued expense | -79.59%2.28K | -15.90%30.97K | 5.46%11.98K | -76.28%2.16K | -20.18%5.67K | 20.75%11.16K | 59.20%36.82K | 626.09%11.36K | 9.69%9.12K | -1.62%7.1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | --0 | -240.54%-52 | -120.93%-9 | 0.00%-1 | -400.00%-21 | -75.00%-21 | 268.18%37 | 168.75%43 | 50.00%-1 | 138.89%7 |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -98.11%1 | 231.25%53 | 0.00%10 | 0.00%11 | 700.00%32 | 231.25%53 | -57.89%16 | --10 | 450.00%11 | -80.00%4 |
| Current changes in cash | ---- | -240.54%-52 | -120.93%-9 | 0.00%-1 | -400.00%-21 | -75.00%-21 | 268.18%37 | 168.75%43 | 50.00%-1 | 138.89%7 |
| End cash Position | -96.88%1 | -98.11%1 | -98.11%1 | 0.00%10 | 0.00%11 | 700.00%32 | 231.25%53 | 231.25%53 | --10 | 450.00%11 |
| Free cash from | --0 | -240.54%-52 | -120.93%-9 | 0.00%-1 | -400.00%-21 | -75.00%-21 | 268.18%37 | 168.75%43 | 50.00%-1 | 138.89%7 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.